Literature DB >> 25624489

Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses.

Jennifer E Cox1, Lydia V McClure1, Andrei Goga2, Christopher S Sullivan3.   

Abstract

Diverse viruses encode regulatory RNAs called microRNAs (miRNAs). Despite much progress, the functions of the majority of viral miRNAs remain unknown. Most previous studies have used biochemical methods to uncover targets of viral miRNAs, but it is unclear what fraction of these targets is functionally important. Here, we apply an alternative strategy based on the premise that assorted viral miRNAs will share functionality. Screening a library of >70 human viral miRNAs showed that three unrelated miRNAs from distantly related herpesviruses significantly inhibited IFN signaling. Strikingly, each of these miRNAs directly reduced expression of the cyclic AMP-responsive element-binding protein (CBP), which as part of the p300-CBP complex, mediates IFN signaling. We show that both 5' and 3' derivatives from Epstein-Barr virus (EBV) encoded miR-BART-18 precursor miRNA (pre-miRNA) and the orthologous pre-miRNA from Rhesus lymphocryptovirus contribute to reducing IFN signaling. Thus, through both convergent and divergent evolutionary mechanisms, varied herpesviral miRNAs share the ability to decrease IFN signaling. Restoring miR-BART-18 to cells infected with an EBV miRNA mutant conveyed a cellular growth advantage upon IFN treatment, and relevant miRNAs from other herpesviruses were able to complement this activity. Blocking miR-BART-18 function in an EBV(+) tumor cell line renders cells more susceptible to IFN-mediated effects. These findings provide a mechanism that can at least partially explain the resistance of some EBV-associated tumors to IFN therapy. Our work suggests that similar pan-viral-miRNA functional-based screening strategies are warranted for determining relevant activities of other viral miRNAs.

Entities:  

Keywords:  HCMV; KSHV; RNAi; latency; p300/CBP

Mesh:

Substances:

Year:  2015        PMID: 25624489      PMCID: PMC4330743          DOI: 10.1073/pnas.1417891112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

2.  A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses.

Authors:  Adam Grundhoff; Christopher S Sullivan; Don Ganem
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

3.  Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3.

Authors:  Te Du; Guoying Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-20       Impact factor: 11.205

Review 4.  Viruses, microRNAs, and host interactions.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

Review 5.  Herpesvirus microRNAs: phenotypes and functions.

Authors:  Bryan R Cullen
Journal:  Curr Opin Virol       Date:  2011-09       Impact factor: 7.090

6.  Evolutionary conservation of primate lymphocryptovirus microRNA targets.

Authors:  Rebecca L Skalsky; Dong Kang; Sarah D Linnstaedt; Bryan R Cullen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

7.  Over-expression of human cytomegalovirus miR-US25-2-3p downregulates eIF4A1 and inhibits HCMV replication.

Authors:  Manlong Qi; Ying Qi; Yanping Ma; Rong He; Yaohua Ji; Zhengrong Sun; Qiang Ruan
Journal:  FEBS Lett       Date:  2013-06-06       Impact factor: 4.124

Review 8.  The renaissance of interferon therapy for the treatment of myeloid malignancies.

Authors:  Jean-Jacques Kiladjian; Ruben A Mesa; Ronald Hoffman
Journal:  Blood       Date:  2011-03-09       Impact factor: 22.113

9.  Epstein-Barr virus maintains lymphomas via its miRNAs.

Authors:  D T Vereide; E Seto; Y-F Chiu; M Hayes; T Tagawa; A Grundhoff; W Hammerschmidt; B Sugden
Journal:  Oncogene       Date:  2013-03-18       Impact factor: 9.867

10.  Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.

Authors:  Hong-Jie Yang; Tie-Jun Huang; Chang-Fu Yang; Li-Xia Peng; Ran-Yi Liu; Guang-Da Yang; Qiao-Qiao Chu; Jia-Ling Huang; Na Liu; Hong-Bing Huang; Zhen-Yu Zhu; Chao-Nan Qian; Bi-Jun Huang
Journal:  Virol J       Date:  2013-10-26       Impact factor: 4.099

View more
  4 in total

Review 1.  The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer.

Authors:  Ugo Moens; Kashif Rasheed; Ibrahim Abdulsalam; Baldur Sveinbjørnsson
Journal:  Viruses       Date:  2015-04-10       Impact factor: 5.048

Review 2.  MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations.

Authors:  Jennifer Louten; Michael Beach; Kristina Palermino; Maria Weeks; Gabrielle Holenstein
Journal:  Biomark Insights       Date:  2016-01-18

Review 3.  lncRNA-mediated regulation of the interferon response.

Authors:  Saba Valadkhan; Lalith S Gunawardane
Journal:  Virus Res       Date:  2015-10-22       Impact factor: 3.303

Review 4.  How Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and Viruses.

Authors:  Marina I Arleevskaya; Olga A Kravtsova; Julie Lemerle; Yves Renaudineau; Anatoly P Tsibulkin
Journal:  Front Microbiol       Date:  2016-08-17       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.